InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Johnson Kenneth Erland. Insider active across 2 companies, notably Xeris Pharmaceuticals INC. In total, 8 reports have been logged. Activity tracked since 3 January 2022. The latest transaction was disclosed on 31 January 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Johnson Kenneth Erland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
15,476 shares@ US$3.5647.8% of flowCommon StockSEC:0001867096-25-000023:0
12,401 shares@ US$3.6139.4% of flowCommon StockSEC:0001867096-25-000013:0
7,497 shares@ US$2.1112.8% of flowCommon StockSEC:0001867096-24-000169:0
175,000 shares0Common StockSEC:0001867096-24-000016:0
100,000 shares0Common StockSEC:0001867096-23-000019:0
75,000 shares0Common StockSEC:0001867096-22-000010:0
11,250 sharesCommon StockSEC:0000899243-21-039319:0
11,250 sharesCommon StockSEC:0000899243-21-039246:0
8 of 8 declarations
About Johnson Kenneth Erland
JOHNSON KENNETH ERLAND is a declarant linked to Xeris Biopharma Holdings, Inc. and Xeris Pharmaceuticals INC, with 8 filings in total. In the recent filings available, the reported amounts are related to attributions, between 2021-10-05 and 2025-02-03.
